Archives

by in
Entry Author Date Location
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
NGM Biopharmaceuticals Secures $13,485,015 Series C Funding Round 05/03/13 San Francisco
NGM Biopharmaceuticals Obtains $51,000,000 Series B Funding Round 03/15/10 San Francisco
NGM Biopharmaceuticals Garners $9,600,000 New Funding 12/31/09 San Francisco
NGM Biopharmaceuticals Obtains $8,500,000 New Funding 03/31/09 San Francisco
Page 1 of 1